Method of producing a cationic liposomal preparation comprising a lipophilic compound

Details for Australian Patent Application No. 2003280505 (hide)

Owner MediGene AG

Inventors Schramel, Oliver; Mundus, Carsten; Peymann, Toralf; Schulze, Brita; Haas, Heinrich; Michaelis, Uwe; Welz, Christian; Fichert, Thomas; Teifel, Michael

Agent Davies Collison Cave

Pub. Number AU-B-2003280505

PCT Number PCT/EP2003/0067

PCT Pub. Number WO2004/002468

Priority 03004744.3 04.03.03 EP; 60/391,246 26.06.02 US; 60/391,245 26.06.02 US; 02018724.1 21.08.02 EP

Filing date 26 June 2003

Wipo publication date 19 January 2004

Acceptance publication date 15 January 2009

International Classifications

A61K 31/335 (2006.01) - having oxygen as the only ring hetero atom, e.g. fungichromin

A61K 9/127 (2006.01) Medicinal preparations characterised by special physical form - Liposomes

A61K 31/337 (2006.01) - having four-membered rings, e.g. taxol

A61K 31/47 (2006.01) - Quinolines

A61K 31/4745 (2006.01)

A61K 47/24 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - containing atoms other than carbon, hydrogen, halogen, oxygen, nitrogen or sulfur

A61K 47/28 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Steroids

A61K 47/34 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61K 49/18 (2006.01) Preparations for testing

A61P 35/00 (2006.01) Antineoplastic agents

C07D 471/14 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

Event Publications

26 February 2004 Complete Application Filed

  Priority application(s): 03004744.3 04.03.03 EP; 60/391,246 26.06.02 US; 60/391,245 26.06.02 US; 02018724.1 21.08.02 EP

4 March 2004 Application Open to Public Inspection

  Published as AU-B-2003280505

5 October 2006 Assignment before Grant

  MediGene Oncology GmbH The application has been assigned to MediGene AG 2004

15 January 2009 Application Accepted

  Published as AU-B-2003280505

14 May 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003280506-SPRAY DEVICE AND METHOD

2003280504-Nutritional composition for detoxification and cancer prevention